An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts

Cell Death & Disease
M PinazzaS Indraccolo

Abstract

Despite some success with certain hematological malignancies and in contrast with the strong pro-apoptotic effects measured in vitro, the overall response rate of acute lymphoblastic leukemia (ALL) to histone deacetylase inhibitors (HDACis) is low. With the aim to improve the understanding of how HDACis work in vivo, we investigated the therapeutic efficacy of the clinically approved HDACi Givinostat in a collection of nine pediatric human T-ALL engrafted systemically in NOD/SCID mice. We observed highly heterogeneous antileukemia responses to Givinostat, associated with reduction of the percentage of infiltrating blasts in target organs, induction of apoptosis and differentiation. These effects were not associated with the T-ALL cytogenetic subgroup. Transcriptome analysis disclosed an immediate transcriptional signature enriched in genes involved in cell-cycle regulation and DNA repair, which was validated by quantitative RT-PCR and was associated with in vivo response to this HDACi. Increased phospho-H2AX levels, a marker of DNA damage, were measured in T-ALL cells from Givinostat responders. These results indicate that the induction of the DNA damage response could be an early biomarker of the therapeutic effects of Givinos...Continue Reading

References

May 2, 2003·Annals of the New York Academy of Sciences·Sam ThiagalingamJose F Ponte
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorWilliam K Kelly
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Apr 4, 2007·Statistical Applications in Genetics and Molecular Biology·Rainer Opgen-Rhein, Korbinian Strimmer
Jul 24, 2007·Bioinformatics·Aravind SubramanianJill P Mesirov
Sep 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Guoqiang SunYanhong Shi
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·J-H LeePaul A Marks
Nov 30, 2010·Best Practice & Research. Clinical Haematology·Jules P P Meijerink
Feb 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark KirschbaumEdward Newman
Jun 28, 2011·Leukemia & Lymphoma·Grace I Aldana-MasangkayKathleen M Sakamoto
Aug 26, 2015·Drug Development Research·Saira R AliMichael Z Michael

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE69346

Methods Mentioned

BETA
xenografts
xenograft
acetylation
fluorescence activated cell sorting
protein Assay

Software Mentioned

R
Gene Set Enrichment Analysis ( GSEA )
IPA
PAM
Bioconductor
Affymetrix GeneChip Command Console Software ( AGCC
DAVID
Core Analysis
GSEA

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis